Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mathematical modeling of multi-drugs therapy: a challenge for determining the optimal combinations of antiviral drugs.

Theoretical biology & medical modelling - 25 Sept 2014

Koizumi Yoshiki, Iwami Shingo

Abstract excerpt

In the current era of antiviral drug therapy, combining multiple drugs is a primary approach for improving antiviral effects, reducing the doses of individual drugs, relieving the side effects of strong antiviral drugs, and preventing the emergence of drug-resistant viruses. Although a variety of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to APOBEC-3G Deaminase
Share to Cytidine Deaminase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dose-Response Relationship, Drug

Share to Drug Therapy, Combination

Share to Models, Biological

Share to Virus Replication

Source

Open in PubMed Open full text

Identifiers

PMID: 25252828
DOI: 10.1186/1742-4682-11-41
PMCID: PMC4247767

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25252828-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mathematical modeling of multi-drugs therapy: a challenge for determining the optimal combinations of antiviral drugs.PMID 25252828Read ↗

Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2Semantic proximity Read ↗

Identification of novel antiviral drug combinations in vitro and tracking their developmentSemantic proximity Read ↗

Modeling Suggests a Mechanism of Synergy Between Hepatitis C Virus Entry Inhibitors and Drugs of Other ClassesSemantic proximity Read ↗

Required concentration index quantifies effective drug combinations against hepatitis C virus infectionSemantic proximity Read ↗

Required concentration index quantifies effective drug combinations against hepatitis C virus infection.Semantic proximity Read ↗

Required concentration index quantifies effective drug combinations against hepatitis C virus infectionSemantic proximity Read ↗

The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In VitroSemantic proximity Read ↗

Drug combinations proposed by machine learning on genes/proteins to improve the efficacy of Tecovirimat in the treatment of Monkeypox: A Systematic Review and Network Meta-analysisSemantic proximity Read ↗

A critical subset model provides a conceptual basis for the high antiviral activity of major HIV drugs.Semantic proximity Read ↗

In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral VariantsSemantic proximity Read ↗

Searching for synergy: Identifying optimal antiviral combination therapy using Hepatitis C virus (HCV) agents in a replicon system.Semantic proximity Read ↗

Synergism between remdesivir and ribavirin leads to SARS‐CoV‐2 extinction in cell cultureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.